← Back to headlines
Psyence BioMed Welcomes US Executive Action on Ibogaine Research
Psyence BioMed has expressed its support for recent U.S. executive action aimed at advancing research into Ibogaine.
17 Apr, 13:15 — 17 Apr, 13:15
Sources
Showing 1 of 1 sources



